Effective State-Based Surveillance for Multidrug-Resistant Organisms Related to Health Care-Associated Infections

In September 2008, the Council of State and Territorial Epidemiologists and the Centers for Disease Control and Prevention sponsored a meeting of public health and infection-control professionals to address the implementation of surveillance for multidrug-resistant organisms (MDROs)—particularly tho...

Full description

Saved in:
Bibliographic Details
Published in:Public health reports (1974) 2011-03, Vol.126 (2), p.176-185
Main Authors: Duffy, Jonathan, Sievert, Dawn, Rebmann, Catherine, Kainer, Marion, Lynfield, Ruth, Smith, Perry, Fridkin, Scott
Format: Article
Language:English
Subjects:
Biological and medical sciences
Cross Infection - epidemiology
Cross Infection - prevention & control
Disease Notification - methods
Diseases
Drug resistance
Drug Resistance, Microbial
Epidemiology
General aspects
Government agencies
Health care industry
Human infectious diseases. Experimental studies and models
Humans
Infection Control - organization & administration
Infections
Infectious diseases
Laboratories
Medical sciences
Meetings
Miscellaneous
Multidrug resistant organisms
Notifiable diseases
Pathogens
Patient surveillance
PRACTICE
Prevention
Preventive medicine
Public health
Public health. Hygiene
Public health. Hygiene-occupational medicine
Sentinel Surveillance
State Health Planning and Development Agencies - organization & administration
Surveillance
United States
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In September 2008, the Council of State and Territorial Epidemiologists and the Centers for Disease Control and Prevention sponsored a meeting of public health and infection-control professionals to address the implementation of surveillance for multidrug-resistant organisms (MDROs)—particularly those related to health care-associated infections. The group discussed the role of health departments and defined goals for future surveillance activities. Participants identified the following main points: (1) surveillance should guide prevention and infection-control activities, (2) an MDRO surveillance system should be adaptable and not organism specific, (3) new systems should utilize and link existing systems, and (4) automated electronic laboratory reporting will be an important component of surveillance but will take time to develop. Current MDRO reporting mandates and surveillance methods vary across states and localities. Health departments that have not already done so should be proactive in determining what type of system, if any, will fit their needs.
ISSN:0033-3549
1468-2877
DOI:10.1177/003335491112600208